The estimated Net Worth of Charles Berg is at least $16.8 Million dollars as of 9 March 2023. Mr. Berg owns over 1,431 units of DaVita Inc stock worth over $2,422,725 and over the last 18 years he sold DVA stock worth over $9,035,728. In addition, he makes $5,342,990 as Director at DaVita Inc.
Charles has made over 26 trades of the DaVita Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently he sold 1,431 units of DVA stock worth $107,511 on 9 March 2023.
The largest trade he's ever made was exercising 150,000 units of DaVita Inc stock on 27 February 2012 worth over $3,582,000. On average, Charles trades about 3,585 units every 29 days since 2007. As of 9 March 2023 he still owns at least 15,733 units of DaVita Inc stock.
You can see the complete history of Mr. Berg stock trades at the bottom of the page.
Charles G. Berg J.D. serves as Director of the Company. Mr. Berg has been one of our directors since March 2007, and from November 2016 until December 2017, also served as executive chair of our integrated healthcare business, DaVita Medical Group (“DMG”). On March 25, 2019, Mr. Berg joined the board of directors of Turn-Key Health, an Enclara Healthcare company, serving health plans, provider organizations and their members who experience a serious or advanced illness. From 2008 to 2013, Mr. Berg served as executive chairman of WellCare Health Plans, Inc. (“WellCare”), a provider of managed care services for government-sponsored healthcare programs. Mr. Berg served as non-executive chairman of the board of directors of WellCare from January 2011 until his retirement in May 2013. From January 2007 to April 2009, Mr. Berg was a senior advisor to Welsh, Carson, Anderson & Stowe, a private equity firm. From April 1998 to July 2004, Mr. Berg held various executive positions, including executive vice president-medical delivery, president and chief operating officer with Oxford Health Plans, Inc. (“Oxford”), a health benefit plan provider. He was the chief executive officer when Oxford was acquired by UnitedHealth Group. He then became an executive of UnitedHealth Group and was primarily responsible for integrating the Oxford business. Mr. Berg currently serves as a member of the Operating Council & Senior Advisory Board of Consonance Capital Partners, a private equity firm, and the board of directors of Justworks, Inc., a private human resources and payment company. Mr. Berg is an experienced business leader with significant experience in the healthcare industry and brings an understanding of the operational, financial and regulatory aspects of our industry and business.
As the Director of DaVita Inc, the total compensation of Charles Berg at DaVita Inc is $5,342,990. There are 2 executives at DaVita Inc getting paid more, with Javier Rodriguez having the highest compensation of $16,853,500.
Charles's mailing address filed with the SEC is C/O DAVITA INC., 2000 16TH STREET, DENVER, CO, 80202.
Over the last 22 years, insiders at DaVita Inc have traded over $539,813,199 worth of DaVita Inc stock and bought 20,841,023 units worth $1,590,012,094 . The most active insiders traders include Hathaway Incbuffett Warren ..., R. Ted Weschler, und Kent J Thiry. On average, DaVita Inc executives and independent directors trade stock every 12 days with the average trade being worth of $12,626,872. The most recent stock trade was executed by Kathleen Alyce Waters on 28 August 2024, trading 26,333 units of DVA stock currently worth $1,999,991.
about davita kidney care davita kidney care is a division of davita healthcare partners inc., a fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the united states and abroad. a leading provider of dialysis services in the united states, davita kidney care treats patients with chronic kidney failure and end stage renal disease. davita kidney care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. as of march 31, 2015, davita kidney care operated or provided administrative services at 2,197 outpatient dialysis centers located in the united states serving approximately 174,000 patients. the company also operated 93 outpatient dialysis centers located in 10 countries outside the united states. davita kidney care supports numerous programs dedicated to creating positive,
DaVita Inc executives and other stock owners filed with the SEC include: